Skip to Main Content
TRC_PTL_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • Drug Charts
    • Do Not Crush List
    • First-Time Generics
    • Insulin Safety
    • New Drugs
    • Original Container Meds
    • More Charts >
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! PTU Elite: Controlled Substances & Diversion prepares pharmacy technicians to manage controlled substances, covering everything from best practices for filling prescriptions to recordkeeping. Learn More.
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment
  6. Amylin Agonist

Amylin Agonist

  • Diabetes (716)
    • Blood Glucose Meters (12)
    • Complications (120)
    • Diabetes in Pregnancy (6)
    • Diabetes Meds (79)
    • Drug-Induced Hypo/Hyperglycemia (103)
    • Monitoring (99)
    • Natural Medicines/Supplements (12)
    • Prevention (32)
    • Treatment (282)
      • Alpha-Glucosidase Inhibitors (19)
      • Amylin Agonist (16)
      • Bromocriptine (5)
      • Combination Products (20)
      • Gliptins (66)
      • Glitazones (95)
      • GLP-1 (29)
      • Incretin Enhancers/Mimetics (59)
      • Insulin (165)
      • Meglitinides (37)
      • Metformin (102)
      • SGLT2 Inhibitors (52)
      • Sulfonylureas (98)
      • Treatment of Pediatric Metabolic Syndrome (3)
  • Endocrinology (7)
  • Hyperglycemia (34)
  • Hypoglycemia (16)
  • Other (20)
  • Prediabetes (2)
  • Resources (165)
  • Thyroid Disorders (60)
1 - 15 of 16 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: Drugs for Type 2 Diabetes
August 2023
Chart: Comparison of Insulins (United States) September 2021
Chart: Look-Alike/Sound-Alike Medications May 2019
Technician Tutorial: Diabetes 101 March 2019
Algorithm: Management of New-Onset Type 2 Diabetes October 2016
Article: how to manage diabetes during an acute illness March 2013
Commentary: Sick Day Management of Diabetes March 2013
Patient Education: How to Manage Sick Days with Diabetes March 2013
Chart: Stepwise Approach to Selecting Treatments for Type 2 Diabetes (AACE) October 2010
Article: keep all the new diabetes meds straight May 2010
Guideline: AACE Diabetes Management Consensus Statement (2013). May 2010
Guideline: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) May 2010
Commentary: Insulins March 2010
Article: mix-ups with common diabetes meds...glyburide, glipizide, and glimepiride May 2009
Guideline: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) November 2006
  • 1
  • 2
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved